Entzündung und Ernährung bei Mukoviszidose

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Der Pneumologe

• Publication date

  2015-02-15

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s10405-014-0865-x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Omega-3 fatty acids for cystic fibrosis.

  2016cited by this paper
• Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.

  2016cited by this paper
• Oral steroids for long-term use in cystic fibrosis.

  2015cited by this paper
• Lactobacillus reuteri ATCC55730 in Cystic Fibrosis

  2014cited by this paper
• Advances in understanding Pseudomonas

  2014cited by this paper
• Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.

  2014cited by this paper
• Vitamin D supplementation for cystic fibrosis.

  2014cited by this paper
• Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.

  2014cited by this paper
• CFTR: cystic fibrosis and beyond

  2014cited by this paper
• Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.

  2014cited by this paper
• Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis

  2014cited by this paper
• Vitamin D status in children with cystic fibrosis. Associations with inflammation and bacterial colonization.

  2014cited by this paper
• Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections

  2014cited by this paper
• Vitamin D as an anti-microbial and anti-inflammatory therapy for Cystic Fibrosis.

  2014cited by this paper
• Resolution of acute inflammation in the lung.

  2014cited by this paper
• Vitamin E, γ-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers.

  2013cited by this paper
• Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures

  2012cited by this paper
• Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis

  2012cited by this paper
• Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation

  2012cited by this paper
• Association of vitamin D and antimicrobial peptide production during late‐phase allergic responses in the lung

  2012cited by this paper
• The airway microbiome in cystic fibrosis: challenges for therapy

  2011cited by this paper
• 1α,25-Dihydroxyvitamin D₃ inhibits neutrophil recruitment in hamster model of acute lung injury.

  2011cited by this paper
• Cross-Sectional and Longitudinal Comparisons of the Predominant Fecal Microbiota Compositions of a Group of Pediatric Patients with Cystic Fibrosis and Their Healthy Siblings

  2011cited by this paper
• The airway microbiome in cystic fibrosis and implications for treatment

  2011cited by this paper
• Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study

  2010cited by this paper
• Evidence of Intestinal Inflammation in Patients With Cystic Fibrosis

  2010cited by this paper
• Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.

  2010cited by this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response

  2010cited by this paper
• Die Rolle neuer „pro-resolving” Lipidmediatoren bei entzündlichen Lungenerkrankungen

  2010cited by this paper
• Beta-carotene degradation products - formation, toxicity and prevention of toxicity.

  2009cited by this paper
• Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses1

  2009cited by this paper
• Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

  2009cited by this paper
• Differentiated implication of Lactobacillus GG and L. gasseri TMC0356 to immune responses of murine Peyer's patch

  2009cited by this paper
• Oral administration of Bifidobacterium longum prevents gut‐derived Pseudomonas aeruginosa sepsis in mice

  2008cited by this paper
• Prevalence of Low Bone Mass and Deficiencies of Vitamins D and K in Pediatric Patients With Cystic Fibrosis From 3 Canadian Centers

  2008cited by this paper
• Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84.

  2008cited by this paper
• Innate immune activation and cystic fibrosis.

  2008cited by this paper
• The prevalence of cystic fibrosis in the European Union.

  2008cited by this paper
• Vitamin A supplementation for cystic fibrosis.

  2008cited by this paper
• Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells

  2008cited by this paper
• Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3).

  2007cited by this paper
• Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses.

  2007cited by this paper
• Vitamin A supplementation for cystic fibrosis (Protocol)

  2007cited by this paper
• Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study.

  2007cited by this paper
• Fecal Calprotectin: A Quantitative Marker of Colonic Inflammation in Children With Inflammatory Bowel Disease

  2007cited by this paper
• Anti-inflammatory cytokines in cystic fibrosis lung disease

  2006cited by this paper
• Gastrointestinal outcomes and confounders in cystic fibrosis.

  2005cited by this paper
• Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1

  2004cited by this paper
• Association of cystic fibrosis with abnormalities in fatty acid metabolism.

  2004cited by this paper
• Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration

  2004cited by this paper
• Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.

  2003cited by this paper
• Novel pathways and endogenous mediators in anti-inflammation and resolution.

  2003cited by this paper
• Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster.

  2003cited by this paper
• What is cystic fibrosis?

  2002cited by this paper
• Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project

  2002cited by this paper
• The role of vitamins in cystic fibrosis.

  2000cited by this paper
• Intestinal inflammation in cystic fibrosis

  2000cited by this paper
• Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen.

  1999cited by this paper
• Cystic fibrosis: nutritional consequences and management.

  1998cited by this paper
• Anaemia, vitamin E deficiency and failure to thrive in an infant.

  1998cited by this paper
• Management of osteoporosis: is there a role for vitamin K?

  1997cited by this paper
• FREQUENCY OF WIEDEMANN-BECKWITH SYNDROME IN GERMANY; RATE OF HEMIHYPERPLASIA AND OF TUMOURS IN AFFECTED CHILDREN

  1997cited by this paper
• Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress.

  1996cited by this paper
• IMPAIRED BRAINSTEM AUDITORY EVOKED POTENTIALS IN PATIENTS WITH CYSTIC FIBROSIS

  1996cited by this paper
• Vitamin K and the management of patients with cystic fibrosis

  1994cited by this paper
• Short-term changes in erythrocyte alpha-tocopherol content of vitamin E-deficient patients with cystic fibrosis.

  1992cited by this paper
• Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis.

  1989cited by this paper
• Symptomatic vitamin E deficiency in cystic fibrosis.

  1985cited by this paper
• The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas.

  1962cited by this paper

• No citing papers are available for this paper.